| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
AS |
$22.82 |
$176,316 |
I/I |
(7,704) |
199,539 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-11-18 |
4 |
AS |
$46.39 |
$176,712 |
I/I |
(3,750) |
775,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-09-16 |
4 |
AS |
$47.86 |
$181,418 |
I/I |
(3,750) |
837,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-09-17 |
4 |
AS |
$48.30 |
$181,707 |
I/I |
(3,750) |
833,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-12-01 |
4 |
AS |
$23.95 |
$184,503 |
I/I |
(7,704) |
207,243 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-11-04 |
4 |
AS |
$49.32 |
$186,270 |
I/I |
(3,750) |
782,828 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2016-03-21 |
4 |
AS |
$154.91 |
$186,756 |
D/D |
(1,200) |
14,376 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-01 |
4 |
AS |
$20.06 |
$191,425 |
I/I |
(9,545) |
54,525 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-11-05 |
4 |
AS |
$51.03 |
$193,956 |
I/I |
(3,750) |
779,078 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-10-21 |
4 |
AS |
$32.59 |
$195,835 |
D/D |
(6,000) |
2,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-04 |
4 |
AS |
$21.45 |
$196,310 |
I/I |
(9,152) |
22,789 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-11-01 |
4 |
AS |
$25.43 |
$196,386 |
I/I |
(7,704) |
214,947 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2017-05-18 |
4 |
D |
$175.89 |
$200,690 |
D/D |
(1,141) |
15,324 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-10-03 |
4 |
AS |
$26.77 |
$209,296 |
I/I |
(7,704) |
222,651 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-08-01 |
4 |
AS |
$27.47 |
$211,629 |
I/I |
(7,704) |
238,059 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-09-01 |
4 |
AS |
$28.08 |
$216,328 |
I/I |
(7,704) |
230,355 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-12-10 |
4 |
AS |
$57.03 |
$221,099 |
I/I |
(3,750) |
767,828 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2014-05-09 |
4 |
B |
$1.79 |
$224,213 |
I/I |
125,000 |
304,000 |
2.1 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$22.14 |
$227,991 |
I/I |
(10,300) |
85,745 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-06 |
4 |
AS |
$23.63 |
$232,685 |
I/I |
(9,847) |
34,590 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-30 |
4 |
AS |
$20.08 |
$244,566 |
I/I |
(12,179) |
57,786 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-06-18 |
4 |
AS |
$81.67 |
$245,019 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-05 |
4 |
AS |
$20.86 |
$245,543 |
I/I |
(11,771) |
18,768 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2015-10-07 |
4 |
AS |
$145.12 |
$247,878 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-05-09 |
4 |
B |
$1.75 |
$249,858 |
D/D |
142,776 |
142,776 |
2.39 |
- |
|
424 Records found
|
|
Page 12 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
